CEO Stephen Farrell was paid $7,522,385 in fiscal year 2025, the 40th percentile of its disclosed peer group (SEC filing 0000718937-26-000015 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$7,522,385 Stephen Farrell total, FY2025 | 40th CEO pay percentile vs peers | 97:1 CEO-to-median pay ratio | 96.28% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
STAA's next annual pay disclosure, estimated May 14, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Stephen Farrell | $580,000 | $0 | $6,836,000 | $0 | $0 | $0 | $106,385 | $7,522,385 |
| Chief Executive Officer | ||||||||
| Warren Foust | 594,238 | 250,000 | 3,000,016 | 0 | 567,000 | 0 | 29,410 | 4,440,664 |
| President and Chief Operating Officer | ||||||||
| Nathaniel Sisitsky | 488,750 | 75,000 | 1,800,036 | 0 | 381,150 | 0 | 21,026 | 2,765,962 |
| Chief Legal Officer and Corporate Secretary | ||||||||
| Magda Michna | 516,819 | 0 | 1,800,036 | 0 | 353,025 | 0 | 25,872 | 2,695,752 |
| Chief Development Officer | ||||||||
| Deborah Andrews | 810,173 | 0 | 1,400,016 | 0 | 367,538 | 0 | 4,684 | 2,582,411 |
| Chief Financial Officer | ||||||||
| Thomas Frinzi | 167,154 | 0 | 0 | 0 | 0 | 0 | 1,088,761 | 1,255,915 |
| Former President and Chief Executive Officer | ||||||||
| Patrick Williams | 146,070 | 0 | 0 | 0 | 0 | 0 | 780,871 | 926,941 |
| Former Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Stephen Farrell | $7,522,385 | — | — | — |
| Warren Foust | 4,440,664 | 2,903,669 | 3,250,292 | ↑ +1,536,995 |
| Nathaniel Sisitsky | 2,765,962 | 2,131,935 | — | ↑ +634,027 |
| Magda Michna | 2,695,752 | 2,313,683 | — | ↑ +382,069 |
| Deborah Andrews | 2,582,411 | — | — | — |
| Thomas Frinzi | 1,255,915 | 7,821,216 | 10,220,581 | ↓ −6,565,301 |
| Patrick Williams | 926,941 | 2,898,889 | 2,816,869 | ↓ −1,971,948 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read STAAR SURGICAL CO's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper STAA reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Get the STAAR SURGICAL CO Peer Teardown Report
$7,522,385 Stephen Farrell total, FY2025
$199
The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.
Data as of August 18, 2026 · Source: 0000718937-26-000015 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
Reports for STAA
Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:
Order STAA
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.
How we handle your data → Privacy
The list of companies that name STAA as a peer is temporarily unavailable — recheck shortly.
Get the STAAR SURGICAL CO Executive Compensation Report
$1,500
One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.
| Executive | Role | FY2025 total |
|---|---|---|
| Magda Michna | Chief Development Officer | $2,695,752 |
| Nathaniel Sisitsky | General Counsel | $2,765,962 |
| Patrick Williams | CFO | $926,941 |
| Stephen Farrell | CEO | $7,522,385 |
| Thomas Frinzi | Executive | $1,255,915 |
| Warren Foust | President | $4,440,664 |
| Deborah Andrews | CFO | $2,582,411 |
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Aimee S. Weisner | Independent Director | $31,799 |
| Arthur C. Butcher | Independent Director | $243,394 |
| Elizabeth Yeu, M.D | Independent Director | $293,586 |
| K. Peony Yu, M.D | Former director (through FY2025) | — |
| Lilian Y. Zhou | Independent Director | $448,571 |
| Louis E. Silverman | Independent Director | $254,787 |
| Wei Jiang | Director | $1,536,047 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Magda Michna | Chief Development Officer | 2026-05-08 | D | 1,680 | $27 | $44,839 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-08 | D | 3,448 | 27 | 92,027 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-15 | — | 1,100 | — | — | 1 insider, 1 accrual row | ||
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 2,199 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 3,666 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 14,662 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | D | 7,460 | 32 | 239,242 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 2,199 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 10,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | D | 559 | 32 | 17,927 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | D | 1,118 | 32 | 35,854 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | D | 2,431 | 32 | 77,962 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | D | 5,595 | 32 | 179,432 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 10,997 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 7,331 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 7,331 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | D | 1,865 | 32 | 59,811 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 7,331 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | A | 5,233 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | A | 10,466 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 5,499 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 14,662 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 3,666 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | D | 3,730 | 32 | 119,621 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | D | 3,730 | 32 | 119,621 | Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | D | 1,877 | 32 | 60,195 | Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | A | 5,233 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | D | 3,755 | 32 | 120,423 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 1,100 | 0 | 0 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 5,499 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | A | 10,466 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 7,331 | 0 | 0 | Common | Form 4 ↗ |
| Lilian Y. Zhou | Director | 2026-06-12 | A | 3,530 | 28 | 99,865 | Common | Form 4 ↗ |
| Lilian Y. Zhou | Director | 2026-06-18 | A | 3,091 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Neal C. Bradsher | Director | 2026-06-18 | A | 11,145 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Wei Jiang | Director | 2026-06-18 | A | 6,182 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Wei Jiang | Director | 2026-06-18 | A | 10,683 | 0 | 0 | Common | Form 4 ↗ |
| Louis E. Silverman | Director | 2026-06-18 | A | 10,683 | 0 | 0 | Common | Form 4 ↗ |
| Lilian Y. Zhou | Director | 2026-06-18 | A | 5,572 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Arthur C. Butcher | Director | 2026-06-18 | A | 3,709 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Wei Jiang | Director | 2026-06-18 | D | 10,683 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Louis E. Silverman | Director | 2026-06-18 | A | 6,182 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Louis E. Silverman | Director | 2026-06-18 | D | 10,683 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Arthur C. Butcher | Director | 2026-06-18 | D | 5,341 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher M. Wang | Director | 2026-06-18 | A | 11,145 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Arthur C. Butcher | Director | 2026-06-18 | A | 5,341 | 0 | 0 | Common | Form 4 ↗ |
| Arthur C. Butcher | Director | 2026-06-18 | A | 4,458 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Richard T. LeBuhn | Director | 2026-06-18 | A | 11,145 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-06-25 | D | 6,480 | 31 | 202,241 | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-06-25 | A | 13,955 | — | — | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-06-25 | D | 13,955 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-07-31 | D | 20,787 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-07-31 | A | 20,787 | — | — | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-07-31 | D | 20,787 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-07-31 | D | 10,576 | 24 | 257,631 | Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-07-31 | D | 10,576 | 24 | 257,631 | Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-07-31 | A | 20,787 | — | — | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-08-14 | A | 5,499 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | A | 4,975 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 131,830 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | D | 3,730 | 26 | 97,651 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-08-14 | D | 559 | 26 | 14,635 | Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 7,331 | 0 | 0 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-08-14 | A | 5,499 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | A | 5,233 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | A | 8,952 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | A | 5,233 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 7,331 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 22,493 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | D | 1,865 | 26 | 48,826 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-14 | — | 1,100 | — | — | 1 insider, 1 accrual row | ||
| Magda Michna | Chief Development Officer | 2026-08-14 | A | 1,100 | 26 | 28,798 | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | D | 2,662 | 26 | 69,691 | Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 3,666 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 123,659 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 37,962 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 40,471 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 3,666 | 0 | 0 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-08-14 | D | 2,797 | 26 | 73,225 | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | A | 29,159 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Magda Michna | Chief Development Officer | 2026-05-08 | D | 1,680 | $27 | $44,839 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-08 | D | 3,448 | 27 | 92,027 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 1,100 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 2,199 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 3,666 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 14,662 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | D | 7,460 | 32 | 239,242 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 2,199 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 10,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | D | 559 | 32 | 17,927 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | D | 1,118 | 32 | 35,854 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | D | 2,431 | 32 | 77,962 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | D | 5,595 | 32 | 179,432 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 10,997 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 7,331 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 7,331 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | D | 1,865 | 32 | 59,811 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 7,331 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | A | 5,233 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | A | 10,466 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 5,499 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 14,662 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 3,666 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | D | 3,730 | 32 | 119,621 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | D | 3,730 | 32 | 119,621 | Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | D | 1,877 | 32 | 60,195 | Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | A | 5,233 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | D | 3,755 | 32 | 120,423 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 1,100 | 0 | 0 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-05-15 | A | 5,499 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Andrews | Interim Co-CEO and CFO | 2026-05-15 | A | 10,466 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | Interim Co-CEO and Pres. & COO | 2026-05-15 | A | 7,331 | 0 | 0 | Common | Form 4 ↗ |
| Lilian Y. Zhou | Director | 2026-06-12 | A | 3,530 | 28 | 99,865 | Common | Form 4 ↗ |
| Lilian Y. Zhou | Director | 2026-06-18 | A | 3,091 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Neal C. Bradsher | Director | 2026-06-18 | A | 11,145 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Wei Jiang | Director | 2026-06-18 | A | 6,182 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Wei Jiang | Director | 2026-06-18 | A | 10,683 | 0 | 0 | Common | Form 4 ↗ |
| Louis E. Silverman | Director | 2026-06-18 | A | 10,683 | 0 | 0 | Common | Form 4 ↗ |
| Lilian Y. Zhou | Director | 2026-06-18 | A | 5,572 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Arthur C. Butcher | Director | 2026-06-18 | A | 3,709 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Wei Jiang | Director | 2026-06-18 | D | 10,683 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Louis E. Silverman | Director | 2026-06-18 | A | 6,182 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Louis E. Silverman | Director | 2026-06-18 | D | 10,683 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Arthur C. Butcher | Director | 2026-06-18 | D | 5,341 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Christopher M. Wang | Director | 2026-06-18 | A | 11,145 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Arthur C. Butcher | Director | 2026-06-18 | A | 5,341 | 0 | 0 | Common | Form 4 ↗ |
| Arthur C. Butcher | Director | 2026-06-18 | A | 4,458 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Richard T. LeBuhn | Director | 2026-06-18 | A | 11,145 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-06-25 | D | 6,480 | 31 | 202,241 | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-06-25 | A | 13,955 | — | — | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-06-25 | D | 13,955 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-07-31 | D | 20,787 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-07-31 | A | 20,787 | — | — | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-07-31 | D | 20,787 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-07-31 | D | 10,576 | 24 | 257,631 | Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-07-31 | D | 10,576 | 24 | 257,631 | Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-07-31 | A | 20,787 | — | — | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-08-14 | A | 5,499 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | A | 4,975 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 131,830 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | D | 3,730 | 26 | 97,651 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-08-14 | D | 559 | 26 | 14,635 | Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 7,331 | 0 | 0 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-08-14 | A | 5,499 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | A | 5,233 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | A | 8,952 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | A | 5,233 | 0 | 0 | Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 7,331 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 22,493 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | D | 1,865 | 26 | 48,826 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-08-14 | A | 1,100 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-08-14 | A | 1,100 | 26 | 28,798 | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | D | 2,662 | 26 | 69,691 | Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 3,666 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 123,659 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 37,962 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 40,471 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Warren Foust | President and CEO | 2026-08-14 | A | 3,666 | 0 | 0 | Common | Form 4 ↗ |
| Magda Michna | Chief Development Officer | 2026-08-14 | D | 2,797 | 26 | 73,225 | Common | Form 4 ↗ |
| Deborah Andrews | Chief Financial Officer & EVP | 2026-08-14 | A | 29,159 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Magda Michna | RSU | 2025-03-14 | — | — | 8,798 | — | $150,006 |
| Stephen Farrell | RSU | 2025-02-26 | — | — | 200,000 | — | 3,418,000 |
| Warren Foust | RSU | 2025-03-14 | — | — | 58,651 | — | 1,000,000 |
| Deborah Andrews | PSU | 2025-06-25 | 20,933 | 41,866 | — | 83,732 | 700,000 |
| Warren Foust | RSU | 2025-03-14 | — | — | 29,326 | — | 500,008 |
| Nathaniel Sisitsky | RSU | 2025-03-14 | — | — | 43,989 | — | 750,012 |
| Warren Foust | PSU | 2025-03-14 | 14,663 | 29,326 | — | 58,652 | 500,008 |
| Magda Michna | RSU | 2025-03-14 | — | — | 43,989 | — | 750,012 |
| Stephen Farrell | PSU | 2025-02-26 | 100,000 | 200,000 | — | 400,000 | 3,418,000 |
| Magda Michna | PSU | 2025-03-14 | 21,995 | 43,989 | — | 87,978 | 750,012 |
| Magda Michna | PSU | 2025-03-14 | 4,399 | 8,798 | — | 17,596 | 150,006 |
| Nathaniel Sisitsky | PSU | 2025-03-14 | 21,995 | 43,989 | — | 87,978 | 750,012 |
| Warren Foust | PSU | 2025-03-14 | 29,326 | 58,651 | — | 117,302 | 1,000,000 |
| Nathaniel Sisitsky | PSU | 2025-03-14 | 4,399 | 8,798 | — | 17,596 | 150,006 |
| Nathaniel Sisitsky | RSU | 2025-03-14 | — | — | 8,798 | — | 150,006 |
| Deborah Andrews | RSU | 2025-06-25 | — | — | 41,867 | — | 700,016 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Magda Michna | $900,018 | $900,018 | $0 | 50.0% |
| Stephen Farrell | 3,418,000 | 3,418,000 | 0 | 50.0% |
| Warren Foust | 1,500,008 | 1,500,008 | 0 | 50.0% |
| Deborah Andrews | 700,016 | 700,000 | 0 | 50.0% |
| Nathaniel Sisitsky | 900,018 | 900,018 | 0 | 50.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Magda Michna | Option | 3,605 | 67.63 | — |
| Warren Foust | RSU | 16,350 | — | 385,860 |
| Thomas Frinzi | RSU | 24,796 | — | 585,186 |
| Nathaniel Sisitsky | Option | 6,524 | 37.64 | — |
| Warren Foust | PSU | 87,977 | — | 2,076,257 |
| Thomas Frinzi | RSU | 29,269 | — | 690,748 |
| Stephen Farrell | RSU | 200,000 | — | 4,720,000 |
| Warren Foust | Option | 9,153 | 37.64 | — |
| Stephen Farrell | PSU | 200,000 | — | 4,720,000 |
| Deborah Andrews | RSU | 41,867 | — | 988,061 |
| Warren Foust | RSU | 87,977 | — | 2,076,257 |
| Magda Michna | RSU | 52,787 | — | 1,245,773 |
| Nathaniel Sisitsky | PSU | 52,787 | — | 1,245,773 |
| Magda Michna | PSU | 52,787 | — | 1,245,773 |
| Nathaniel Sisitsky | RSU | 52,787 | — | 1,245,773 |
| Deborah Andrews | PSU | 41,866 | — | 988,038 |
| Magda Michna | RSU | 12,356 | — | 291,602 |
| Nathaniel Sisitsky | RSU | 7,312 | — | 172,563 |
| Nathaniel Sisitsky | RSU | 11,654 | — | 275,034 |
| Magda Michna | RSU | 4,683 | — | 110,519 |
| Warren Foust | RSU | 6,777 | — | 159,937 |
| Stephen Farrell | RSU | 921 | — | 21,736 |
| Warren Foust | Option | 5,218 | 67.63 | — |
| Magda Michna | Option | 6,917 | 37.64 | — |
| Nathaniel Sisitsky | Option | 13,287 | 32.14 | — |
STAAR compensation philosophy is to pay our worldwide employees competitively with similar positions, talent and experience in the applicable labor market.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Semler Brossy |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-04-20 | 39,737,385 | 1,454,186 | 82,750 | 96.28% | Passed |
| 2025 | 2025-06-18 | 41,130,690 | 1,049,897 | 24,667 | 97.45% | Passed |
| 2024 | 2024-06-20 | 33,982,598 | 6,912,213 | 26,835 | 83.04% | Passed |
| 2023 | 2023-06-15 | 35,577,495 | 1,838,486 | 74,938 | 94.9% | Passed |
| 2022 | 2022-06-16 | 37,903,986 | 1,514,494 | 219,269 | 95.63% | Passed |
| 2021 | 2021-06-24 | 35,061,105 | 929,457 | 55,181 | 97.27% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-04-20 | 96.28%a |
| 2025 | 2025-06-18 | 97.45%b |
| 2024 | 2024-06-20 | 83.04%c |
a. Approved under the standard stated in the filing — “Compensation of named executive officers ("say-on-pay") For Majority of votes present in person or by proxy and entitled to vote thereon Abstentions have the effect of a vote against;”.
b. Approved under the standard stated in the filing — “Compensation of named executive officers ("say-on-pay") For Majority of votes present in person or by proxy and entitled to vote thereon Abstentions have the effect of a vote against;”.
c. Approved under the standard stated in the filing — “Compensation of named executive officers ("say-on-pay") For Majority of votes present in person or by proxy and entitled to vote thereon Abstentions have the effect of a vote against;”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 97 : 1 |
|---|---|
| CEO total compensation | $7,522,385 |
| Median employee compensation | $89,344 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Wei JiangNot independent · Audit · Nominating/Governance | $58,036 | $180,009 | $0 | — | $1,298,002 | $1,536,047 |
| Lilian Y. ZhouIndependent · Audit (Chair) · Nominating and Governance | 80,962 | 0 | 220,009 | — | 147,600 | 448,571 |
| Elizabeth Yeu, M.DIndependent · Audit · Nominating/Governance · Compensation | 113,585 | 89,996 | 90,005 | — | 0 | 293,586 |
| Louis E. SilvermanIndependent · Compensation (Chair) · Nominating and Governance | 47,500 | 180,009 | 27,278 | — | 0 | 254,787 |
| Arthur C. ButcherIndependent · Audit | 63,393 | 89,996 | 90,005 | — | 0 | 243,394 |
| Aimee S. WeisnerIndependent · Compensation · Nominating/Governance | 31,799 | 0 | 0 | — | 0 | 31,799 |
| K. Peony Yu, M.DIndependent · Not standing for re-election · Departed during FY | 0 | 0 | 0 | 0 | 0 | 0 |
| Thomas G. FrinziEmployee director · Not standing for re-election · Departed during FY | 0 | 0 | 0 | — | 0 | 0 |
| Stephen C. FarrellEmployee director · Audit · Not standing for re-election · Departed during FY | 0 | 0 | 0 | — | 0 | 0 |
| Richard T. LeBuhnIndependent · Compensation · Partial-year service · Newly elected | — | — | — | — | — | — |
| Christopher M. WangIndependent · Audit · Compensation · Nominating and Governance · Partial-year service · Newly elected | — | — | — | — | — | — |
| Neal C. BradsherIndependent · Board Chair · Nominating and Governance (Chair) · Partial-year service · Newly elected | — | — | — | — | — | — |
| Annual cash retainer | $50,000 |
|---|---|
| Annual equity retainer | $180,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 15,000 / 15,000 |
| Stock ownership guideline | 3x base annual cash retainer (directors); 3x annual base salary (CEO) |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $395,275 |
| Equity awards (grant-date value) | $540,010 |
| All other compensation | $1,445,602 |
| Total cost of the board | $2,380,887 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies STAAR SURGICAL CO names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including STAAR SURGICAL CO.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Merit Medical Systems, Inc. | 2025 | Fred Lampropoulos | $1,890,000 | $9,313,606 | $0 | $1,882,894 | $13,755,143 |
| 2 | Glaukos Corp. | 2025 | Thomas Burns | 850,000 | 7,649,947 | 3,527,497 | 0 | 12,034,087 |
| 3 | iRhythm Technologies, Inc. | 2025 | Quentin Blackford | 700,003 | 8,919,457 | 0 | 1,350,000 | 11,003,163 |
| 4 | Alphatec Holdings, Inc. | 2025 | Patrick Miles | 762,000 | 8,859,650 | 0 | 600,000 | 10,260,507 |
| 5 | Avanos Medical, Inc. | 2025 | David Pacitti | 751,705 | 7,000,000 | 0 | 1,148,667 | 9,469,803 |
| 6 | AtriCure, Inc. | 2025 | Michael Carrel | 828,439 | 7,203,478 | 0 | 1,171,703 | 9,217,620 |
| 7 | AxoGen, Inc. | 2025 | Michael Dale | 775,865 | 7,342,895 | 0 | 906,133 | 9,047,454 |
| 8 | Inspire Medical Systems, Inc. | 2025 | Timothy Herbert | 750,572 | 5,999,655 | 0 | 961,557 | 7,711,784 |
| 9 | UFP Technologies, Inc. | 2025 | R. Jeffrey Bailly | 789,000 | 5,377,499 | — | 1,260,934 | 7,648,440 |
| 10 | STAAR SURGICAL CO | 2025 | Stephen Farrell | 580,000 | 6,836,000 | 0 | 0 | 7,522,385 |
| 11 | Artivion, Inc. | 2025 | J. Patrick Mackin | 835,145 | 5,006,990 | 0 | 991,368 | 6,883,108 |
| 12 | Tandem Diabetes Care, Inc. | 2025 | John Sheridan | 790,583 | 5,367,796 | 0 | 674,090 | 6,858,503 |
| 13 | Inari Medical, Inc. | 2023 | Andrew Hykes | 700,000 | 2,606,744 | 937,488 | 826,000 | 5,083,365 |
| 14 | RxSight, Inc. | 2025 | Ron Kurtz | 630,625 | 0 | 3,816,530 | 202,935 | 4,650,661 |
| 15 | LeMaitre Vascular, Inc. | 2025 | George LeMaitre | 806,347 | 1,050,000 | 1,050,000 | 680,015 | 3,780,990 |
| 16 | Penumbra, Inc. | 2025 | Adam Elsesser | 850,000 | 0 | 0 | 0 | 851,621 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| STAAR SURGICAL CO | 135% | RSU 50 · PSU 50 | No | Semler Brossy |
| Alphatec Holdings, Inc. | 157% | PSU 50 · RSU 50 | No | Compensia |
| Artivion, Inc. | 118.7% | PSU 50 · RSU 50 | No | Willis Towers Watson |
| AtriCure, Inc. | 141% | PSU 70 · RSU 30 | No | Korn Ferry |
| Avanos Medical, Inc. | 139% | PSU 50 · RSU 25 · Options 25 | No | Meridian Compensation Partners |
| AxoGen, Inc. | 116.79% | PSU 50 · RSU 50 | No | Aon |
| Glaukos Corp. | 177.5% | RSU 50 · PRSU 50 | No | Frederic W. Cook & Co., Inc. |
| Inari Medical, Inc. | 118% | RSU 75 · Option 25 | not disclosed | FW Cook |
| Inspire Medical Systems, Inc. | 111.4% | PSU 50 · RSU 50 | No | Aon |
| iRhythm Technologies, Inc. | 173% | RSU 50 · PSU 50 | Yes — Relative TSR | Aon and Mercer |
| LeMaitre Vascular, Inc. | not disclosed | Option 50 · RSU 25 · PSU 25 | No | not disclosed |
| Merit Medical Systems, Inc. | 124.53% | PSU 60 · RSU 40 | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer & Partners, LLC |
| Penumbra, Inc. | not disclosed | not disclosed | No | Compensia |
| RxSight, Inc. | 32.18% | Option 100 | not disclosed | Aon |
| Tandem Diabetes Care, Inc. | 87% | PSU 50 · RSU 50 | Yes — TSR performance compared to the Russell 3000 index in the three-year period between 2025 and 2027 | WTW |
| UFP Technologies, Inc. | not disclosed | not disclosed | No | Pearl Meyer |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Stephen Farrell | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Compensation Tables” · page 40. As printed: 7,522,385. Filing ↗machine: r3 · c16 · span 1045477–1045486 |
| 2 | Section 01, Warren Foust | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Compensation Tables” · page 40. As printed: 4,440,664. Filing ↗machine: r7 · c16 · span 1071122–1071131 |
| 3 | Section 01, Nathaniel Sisitsky | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Compensation Tables” · page 40. As printed: 2,765,962. Filing ↗machine: r13 · c16 · span 1109669–1109678 |
| 4 | Section 01, Magda Michna | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Compensation Tables” · page 40. As printed: 2,695,752. Filing ↗machine: r10 · c16 · span 1090527–1090536 |
| 5 | Section 01, Deborah Andrews | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Compensation Tables” · page 40. As printed: 2,582,411. Filing ↗machine: r5 · c16 · span 1058392–1058401 |
| 6 | Section 01, Thomas Frinzi | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Compensation Tables” · page 40. As printed: 1,255,915. Filing ↗machine: r16 · c16 · span 1128884–1128893 |
| 7 | Section 01, Patrick Williams | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Compensation Tables” · page 40. As printed: 926,941. Filing ↗machine: r19 · c16 · span 1148487–1148494 |
| 8 | Section 03, Magda Michna RSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1370881–1370888 |
| 9 | Section 03, Stephen Farrell RSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1287043–1287052 |
| 10 | Section 03, Warren Foust RSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1331811–1331820 |
| 11 | Section 03, Deborah Andrews PSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1315504–1315511 |
| 12 | Section 03, Warren Foust RSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1337377–1337384 |
| 13 | Section 03, Nathaniel Sisitsky RSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1398823–1398830 |
| 14 | Section 03, Warren Foust PSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1349011–1349018 |
| 15 | Section 03, Magda Michna RSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1365318–1365325 |
| 16 | Section 03, Stephen Farrell PSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1293119–1293128 |
| 17 | Section 03, Magda Michna PSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1376440–1376447 |
| 18 | Section 03, Magda Michna PSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1382510–1382517 |
| 19 | Section 03, Nathaniel Sisitsky PSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1409945–1409952 |
| 20 | Section 03, Warren Foust PSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1342937–1342946 |
| 21 | Section 03, Nathaniel Sisitsky PSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1416030–1416037 |
| 22 | Section 03, Nathaniel Sisitsky RSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1404386–1404393 |
| 23 | Section 03, Deborah Andrews RSU | DEF 14A | 1900-01-01 | 0000718937-26-000015 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1309433–1309440 |
| 24 | Section 07, pay ratio | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “CEO Pay Ratio”. As printed: 97 : 1. Filing ↗ |
| 25 | Section 08, Wei Jiang | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: 1,536,047. Filing ↗machine: span 572660–572889 |
| 26 | Section 08, Lilian Y. Zhou | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: 448,571. Filing ↗machine: span 595667–595894 |
| 27 | Section 08, Elizabeth Yeu, M.D | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: 293,586. Filing ↗machine: span 589999–590226 |
| 28 | Section 08, Louis E. Silverman | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: 254,787. Filing ↗machine: span 578508–578735 |
| 29 | Section 08, Arthur C. Butcher | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: 243,394. Filing ↗machine: span 567009–567236 |
| 30 | Section 08, Aimee S. Weisner | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: 31,799. Filing ↗machine: span 580036–580262 |
| 31 | Section 08, K. Peony Yu, M.D | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 32 | Section 08, Thomas G. Frinzi | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 33 | Section 08, Stephen C. Farrell | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 34 | Section 08, Richard T. LeBuhn | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 35 | Section 08, Christopher M. Wang | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 36 | Section 08, Neal C. Bradsher | DEF 14A | 2026-05-04 | 0000718937-26-000015 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 37 | Section 02, Magda Michna 2026-05-08 | Form 4 | 2026-05-12 | 0001731487-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Warren Foust 2026-05-08 | Form 4 | 2026-05-12 | 0001970778-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Deborah Andrews 2026-05-15 | Form 4 | 2026-05-19 | 0001325697-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Deborah Andrews 2026-05-15 | Form 4 | 2026-05-19 | 0001325697-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Deborah Andrews 2026-05-15 | Form 4 | 2026-05-19 | 0001325697-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Deborah Andrews 2026-05-15 | Form 4 | 2026-05-19 | 0001325697-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Deborah Andrews 2026-05-15 | Form 4 | 2026-05-19 | 0001325697-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Magda Michna 2026-05-15 | Form 4 | 2026-05-19 | 0001731487-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Deborah Andrews 2026-05-15 | Form 4 | 2026-05-19 | 0001325697-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Warren Foust 2026-05-15 | Form 4 | 2026-05-19 | 0001970778-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Lilian Y. Zhou 2026-06-12 | Form 4 | 2026-06-15 | 0001193125-26-271092 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Lilian Y. Zhou 2026-06-18 | Form 4 | 2026-06-22 | 0002003105-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Neal C. Bradsher 2026-06-18 | Form 4 | 2026-06-22 | 0000919574-26-004068 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Wei Jiang 2026-06-18 | Form 4 | 2026-06-22 | 0001867980-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Wei Jiang 2026-06-18 | Form 4 | 2026-06-22 | 0001867980-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Louis E. Silverman 2026-06-18 | Form 4 | 2026-06-22 | 0001249935-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Lilian Y. Zhou 2026-06-18 | Form 4 | 2026-06-22 | 0002003105-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Arthur C. Butcher 2026-06-18 | Form 4 | 2026-06-22 | 0001678249-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Wei Jiang 2026-06-18 | Form 4 | 2026-06-22 | 0001867980-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Louis E. Silverman 2026-06-18 | Form 4 | 2026-06-22 | 0001249935-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Louis E. Silverman 2026-06-18 | Form 4 | 2026-06-22 | 0001249935-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, Arthur C. Butcher 2026-06-18 | Form 4 | 2026-06-22 | 0001678249-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, Christopher M. Wang 2026-06-18 | Form 4 | 2026-06-23 | 0000921895-26-001649 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, Arthur C. Butcher 2026-06-18 | Form 4 | 2026-06-22 | 0001678249-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, Arthur C. Butcher 2026-06-18 | Form 4 | 2026-06-22 | 0001678249-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 02, Richard T. LeBuhn 2026-06-18 | Form 4 | 2026-06-22 | 0000919574-26-004069 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 85 | Section 02, Deborah Andrews 2026-06-25 | Form 4 | 2026-08-04 | 0001325697-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 86 | Section 02, Deborah Andrews 2026-06-25 | Form 4 | 2026-08-04 | 0001325697-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 87 | Section 02, Deborah Andrews 2026-06-25 | Form 4 | 2026-08-04 | 0001325697-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 88 | Section 02, Warren Foust 2026-07-31 | Form 4 | 2026-08-04 | 0001970778-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 89 | Section 02, Deborah Andrews 2026-07-31 | Form 4 | 2026-08-04 | 0001325697-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 90 | Section 02, Deborah Andrews 2026-07-31 | Form 4 | 2026-08-04 | 0001325697-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 91 | Section 02, Deborah Andrews 2026-07-31 | Form 4 | 2026-08-04 | 0001325697-26-000009 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 92 | Section 02, Warren Foust 2026-07-31 | Form 4 | 2026-08-04 | 0001970778-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 93 | Section 02, Warren Foust 2026-07-31 | Form 4 | 2026-08-04 | 0001970778-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 94 | Section 02, Magda Michna 2026-08-14 | Form 4 | 2026-08-18 | 0001731487-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 95 | Section 02, Deborah Andrews 2026-08-14 | Form 4 | 2026-08-18 | 0001325697-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 96 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 97 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 98 | Section 02, Magda Michna 2026-08-14 | Form 4 | 2026-08-18 | 0001731487-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 99 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 100 | Section 02, Magda Michna 2026-08-14 | Form 4 | 2026-08-18 | 0001731487-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 101 | Section 02, Deborah Andrews 2026-08-14 | Form 4 | 2026-08-18 | 0001325697-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 102 | Section 02, Deborah Andrews 2026-08-14 | Form 4 | 2026-08-18 | 0001325697-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 103 | Section 02, Deborah Andrews 2026-08-14 | Form 4 | 2026-08-18 | 0001325697-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 104 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 105 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 106 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 107 | Section 02, Magda Michna 2026-08-14 | Form 4 | 2026-08-18 | 0001731487-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 108 | Section 02, Magda Michna 2026-08-14 | Form 4 | 2026-08-18 | 0001731487-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 109 | Section 02, Deborah Andrews 2026-08-14 | Form 4 | 2026-08-18 | 0001325697-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 110 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 111 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 112 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 113 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 114 | Section 02, Warren Foust 2026-08-14 | Form 4 | 2026-08-18 | 0001970778-26-000014 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 115 | Section 02, Magda Michna 2026-08-14 | Form 4 | 2026-08-18 | 0001731487-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 116 | Section 02, Deborah Andrews 2026-08-14 | Form 4 | 2026-08-18 | 0001325697-26-000011 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 117 | Section 06, 2026 vote | Form 8-K | 2026-06-22 | 0000718937-26-000029 | Item 5.07 · say-on-pay result. As reported: 96.28% (votes for as printed: 39,737,385). Filing ↗ |
| 118 | Section 06, 2025 vote | Form 8-K | 2025-06-18 | 0000950170-25-087967 | Item 5.07 · say-on-pay result. As reported: 97.45% (votes for as printed: 41,130,690). Filing ↗ |
| 119 | Section 06, 2024 vote | Form 8-K | 2024-06-21 | 0000950170-24-076303 | Item 5.07 · say-on-pay result. As reported: 83.04% (votes for as printed: 33,982,598). Filing ↗ |
| 120 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 121 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 122 | Section 09b board cost (computed) | Computed | — | — | Cash 395,275 + equity 540,010 + all other 1,445,602 = 2,380,887, summed across the director compensation table rows.machine: formula: Σ = 2,380,887 |
| 123 | Merit Medical Systems, Inc., Section 10b CEO total | DEF 14A | 2026-03-31 | 0000856982-26-000013 | CEO total compensation as printed in Merit Medical Systems, Inc.'s own proxy. As printed: 13,755,143. Filing ↗machine: r21 · c8 · span 1277869–1277879 |
| 124 | Glaukos Corp., Section 10b CEO total | DEF 14A | 2026-04-16 | 0001193125-26-157829 | CEO total compensation as printed in Glaukos Corp.'s own proxy. As printed: 12,034,087. Filing ↗machine: r6 · c38 · span 1876942–1876952 |
| 125 | iRhythm Technologies, Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001388658-26-000030 | CEO total compensation as printed in iRhythm Technologies, Inc.'s own proxy. As printed: 11,003,163. Filing ↗machine: r2 · c21 · span 1123498–1123508 |
| 126 | Alphatec Holdings, Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0001193125-26-191867 | CEO total compensation as printed in Alphatec Holdings, Inc.'s own proxy. As printed: 10,260,507. Filing ↗machine: t26 · r2 · c25 · span 858148–858158 |
| 127 | Avanos Medical, Inc., Section 10b CEO total | DEF 14A | 2026-03-12 | 0001104659-26-027106 | CEO total compensation as printed in Avanos Medical, Inc.'s own proxy. As printed: 9,469,803. Filing ↗machine: r1 · c53 · span 1674377–1674386 |
| 128 | AtriCure, Inc., Section 10b CEO total | DEF 14A | 2026-04-06 | 0001323885-26-000010 | CEO total compensation as printed in AtriCure, Inc.'s own proxy. As printed: 9,217,620. Filing ↗machine: span 743364–743373 |
| 129 | AxoGen, Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0000805928-26-000057 | CEO total compensation as printed in AxoGen, Inc.'s own proxy. As printed: 9,047,454. Filing ↗machine: r2 · c45 · span 557309–557318 |
| 130 | Inspire Medical Systems, Inc., Section 10b CEO total | DEF 14A | 2026-03-20 | 0001140361-26-010490 | CEO total compensation as printed in Inspire Medical Systems, Inc.'s own proxy. As printed: 7,711,784. Filing ↗machine: r2 · c25 · span 1164868–1164877 |
| 131 | UFP Technologies, Inc., Section 10b CEO total | DEF 14A | 2026-04-30 | 0001628280-26-028710 | CEO total compensation as printed in UFP Technologies, Inc.'s own proxy. As printed: 7,648,440. Filing ↗ |
| 132 | STAAR SURGICAL CO (subject), Section 10b CEO total | DEF 14A | 2026-05-04 | 0000718937-26-000015 | CEO total compensation as printed in STAAR SURGICAL CO's own proxy. As printed: 7,522,385. Filing ↗machine: r3 · c16 · span 1045477–1045486 |
| 133 | Artivion, Inc., Section 10b CEO total | DEF 14A | 2026-04-01 | 0001999371-26-007510 | CEO total compensation as printed in Artivion, Inc.'s own proxy. As printed: 6,883,108. Filing ↗machine: r3 · c9 · span 741873–741882 |
| 134 | Tandem Diabetes Care, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001438133-26-000034 | CEO total compensation as printed in Tandem Diabetes Care, Inc.'s own proxy. As printed: 6,858,503. Filing ↗machine: r3 · c27 · span 866963–866972 |
| 135 | Inari Medical, Inc., Section 10b CEO total | DEF 14A | 2024-03-13 | 0001193125-24-066805 | CEO total compensation as printed in Inari Medical, Inc.'s own proxy. As printed: 5,083,365. Filing ↗machine: r2 · c31 · span 454508–454517 |
| 136 | RxSight, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001193125-26-187240 | CEO total compensation as printed in RxSight, Inc.'s own proxy. As printed: 4,650,661. Filing ↗ |
| 137 | LeMaitre Vascular, Inc., Section 10b CEO total | DEF 14A | 2026-04-14 | 0001193125-26-153877 | CEO total compensation as printed in LeMaitre Vascular, Inc.'s own proxy. As printed: 3,780,990. Filing ↗machine: r3 · c18 · span 564038–564047 |
| 138 | Penumbra, Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0001321732-26-000010 | CEO total compensation as printed in Penumbra, Inc.'s own proxy. As printed: 851,621. Filing ↗machine: span 424797–424804 |
| 139 | Section 10a, Tandem Diabetes Care, Inc. reciprocity | DEF 14A | — | 0001438133-26-000034 | Tandem Diabetes Care, Inc. names STAAR SURGICAL CO in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 140 | Section 10a, Penumbra, Inc. reciprocity | DEF 14A | — | 0001321732-26-000010 | Penumbra, Inc.'s most recent proxy was read; its disclosed peer group does not include STAAR SURGICAL CO. Filing ↗ |
| 141 | Section 10a, Inspire Medical Systems, Inc. reciprocity | DEF 14A | — | 0001140361-26-010490 | Inspire Medical Systems, Inc. names STAAR SURGICAL CO in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 142 | Section 10a, Avanos Medical, Inc. reciprocity | DEF 14A | — | 0001104659-26-027106 | Avanos Medical, Inc.'s most recent proxy was read; its disclosed peer group does not include STAAR SURGICAL CO. Filing ↗ |
| 143 | Section 10a, Artivion, Inc. reciprocity | DEF 14A | — | 0001999371-26-007510 | Artivion, Inc. names STAAR SURGICAL CO in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 144 | Section 10a, iRhythm Technologies, Inc. reciprocity | DEF 14A | — | 0001388658-26-000030 | iRhythm Technologies, Inc.'s most recent proxy was read; its disclosed peer group does not include STAAR SURGICAL CO. Filing ↗ |
| 145 | Section 10a, Inari Medical, Inc. reciprocity | DEF 14A | — | 0001193125-24-066805 | Inari Medical, Inc. names STAAR SURGICAL CO in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 146 | Section 10a, Alphatec Holdings, Inc. reciprocity | DEF 14A | — | 0001193125-26-191867 | Alphatec Holdings, Inc.'s most recent proxy was read; its disclosed peer group does not include STAAR SURGICAL CO. Filing ↗ |
| 147 | Section 10a, AtriCure, Inc. reciprocity | DEF 14A | — | 0001323885-26-000010 | AtriCure, Inc. names STAAR SURGICAL CO in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 148 | Section 10a, AxoGen, Inc. reciprocity | DEF 14A | — | 0000805928-26-000057 | AxoGen, Inc. names STAAR SURGICAL CO in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 149 | Section 10a, Glaukos Corp. reciprocity | DEF 14A | — | 0001193125-26-157829 | Glaukos Corp. names STAAR SURGICAL CO in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 150 | Section 10a, LeMaitre Vascular, Inc. reciprocity | DEF 14A | — | 0001437749-23-010217 | LeMaitre Vascular, Inc.'s most recent proxy was read; its disclosed peer group does not include STAAR SURGICAL CO. Filing ↗ |
| 151 | Section 10a, Merit Medical Systems, Inc. reciprocity | DEF 14A | — | 0000856982-26-000013 | Merit Medical Systems, Inc.'s most recent proxy was read; its disclosed peer group does not include STAAR SURGICAL CO. Filing ↗ |
| 152 | Section 10a, RxSight, Inc. reciprocity | DEF 14A | — | 0001193125-26-187240 | RxSight, Inc. names STAAR SURGICAL CO in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 153 | Section 10a, UFP Technologies, Inc. reciprocity | DEF 14A | — | 0001628280-26-028710 | UFP Technologies, Inc. names STAAR SURGICAL CO in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.
Get the STAAR SURGICAL CO Executive Compensation Report
$1,500